Cargando…

Correction to: Risk Factors for Progression from Subclinical to Clinical Phase of Psoriatic Arthritis: A Case–Control Study

Detalles Bibliográficos
Autores principales: Wang, Yiyi, Ding, Li, Chen, Jihui, Zhang, Lingyan, Yang, Min, Liu, Zhibin, Cheng, Liangliang, Lan, Tianjiao, Li, Gaojie, Gu, Yuanxia, Liu, Yi, Li, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572250/
https://www.ncbi.nlm.nih.gov/pubmed/34476775
http://dx.doi.org/10.1007/s40744-021-00364-2
_version_ 1784595181455015936
author Wang, Yiyi
Ding, Li
Chen, Jihui
Zhang, Lingyan
Yang, Min
Liu, Zhibin
Cheng, Liangliang
Lan, Tianjiao
Li, Gaojie
Gu, Yuanxia
Liu, Yi
Li, Wei
author_facet Wang, Yiyi
Ding, Li
Chen, Jihui
Zhang, Lingyan
Yang, Min
Liu, Zhibin
Cheng, Liangliang
Lan, Tianjiao
Li, Gaojie
Gu, Yuanxia
Liu, Yi
Li, Wei
author_sort Wang, Yiyi
collection PubMed
description
format Online
Article
Text
id pubmed-8572250
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-85722502021-11-15 Correction to: Risk Factors for Progression from Subclinical to Clinical Phase of Psoriatic Arthritis: A Case–Control Study Wang, Yiyi Ding, Li Chen, Jihui Zhang, Lingyan Yang, Min Liu, Zhibin Cheng, Liangliang Lan, Tianjiao Li, Gaojie Gu, Yuanxia Liu, Yi Li, Wei Rheumatol Ther Correction Springer Healthcare 2021-09-02 /pmc/articles/PMC8572250/ /pubmed/34476775 http://dx.doi.org/10.1007/s40744-021-00364-2 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Correction
Wang, Yiyi
Ding, Li
Chen, Jihui
Zhang, Lingyan
Yang, Min
Liu, Zhibin
Cheng, Liangliang
Lan, Tianjiao
Li, Gaojie
Gu, Yuanxia
Liu, Yi
Li, Wei
Correction to: Risk Factors for Progression from Subclinical to Clinical Phase of Psoriatic Arthritis: A Case–Control Study
title Correction to: Risk Factors for Progression from Subclinical to Clinical Phase of Psoriatic Arthritis: A Case–Control Study
title_full Correction to: Risk Factors for Progression from Subclinical to Clinical Phase of Psoriatic Arthritis: A Case–Control Study
title_fullStr Correction to: Risk Factors for Progression from Subclinical to Clinical Phase of Psoriatic Arthritis: A Case–Control Study
title_full_unstemmed Correction to: Risk Factors for Progression from Subclinical to Clinical Phase of Psoriatic Arthritis: A Case–Control Study
title_short Correction to: Risk Factors for Progression from Subclinical to Clinical Phase of Psoriatic Arthritis: A Case–Control Study
title_sort correction to: risk factors for progression from subclinical to clinical phase of psoriatic arthritis: a case–control study
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572250/
https://www.ncbi.nlm.nih.gov/pubmed/34476775
http://dx.doi.org/10.1007/s40744-021-00364-2
work_keys_str_mv AT wangyiyi correctiontoriskfactorsforprogressionfromsubclinicaltoclinicalphaseofpsoriaticarthritisacasecontrolstudy
AT dingli correctiontoriskfactorsforprogressionfromsubclinicaltoclinicalphaseofpsoriaticarthritisacasecontrolstudy
AT chenjihui correctiontoriskfactorsforprogressionfromsubclinicaltoclinicalphaseofpsoriaticarthritisacasecontrolstudy
AT zhanglingyan correctiontoriskfactorsforprogressionfromsubclinicaltoclinicalphaseofpsoriaticarthritisacasecontrolstudy
AT yangmin correctiontoriskfactorsforprogressionfromsubclinicaltoclinicalphaseofpsoriaticarthritisacasecontrolstudy
AT liuzhibin correctiontoriskfactorsforprogressionfromsubclinicaltoclinicalphaseofpsoriaticarthritisacasecontrolstudy
AT chengliangliang correctiontoriskfactorsforprogressionfromsubclinicaltoclinicalphaseofpsoriaticarthritisacasecontrolstudy
AT lantianjiao correctiontoriskfactorsforprogressionfromsubclinicaltoclinicalphaseofpsoriaticarthritisacasecontrolstudy
AT ligaojie correctiontoriskfactorsforprogressionfromsubclinicaltoclinicalphaseofpsoriaticarthritisacasecontrolstudy
AT guyuanxia correctiontoriskfactorsforprogressionfromsubclinicaltoclinicalphaseofpsoriaticarthritisacasecontrolstudy
AT liuyi correctiontoriskfactorsforprogressionfromsubclinicaltoclinicalphaseofpsoriaticarthritisacasecontrolstudy
AT liwei correctiontoriskfactorsforprogressionfromsubclinicaltoclinicalphaseofpsoriaticarthritisacasecontrolstudy